Dallas Texas Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• County: Dallas
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Dallas Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal agreement outlining the terms and conditions regarding the use, ownership, and commercialization of intellectual property between the two entities. This agreement establishes a mutually beneficial partnership with a focus on promoting scientific research, technology transfer, and innovation. Keywords: Dallas Texas Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, ownership, commercialization, partnership, scientific research, technology transfer, innovation. Types of Dallas Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center: 1. Exclusive Collateral License Agreement: This type of agreement grants Gentling, Inc. exclusive rights to use, develop, and commercialize the intellectual property exclusively within the designated field or market. 2. Non-exclusive Collateral License Agreement: This agreement allows Gentling, Inc. non-exclusive rights to utilize the intellectual property alongside other licenses granted to other parties by The University of North Texas Health Science Center. 3. Limited Collateral License Agreement: In this type of agreement, Gentling, Inc. is granted limited rights to use the intellectual property within specific parameters, usually with restrictions on duration, field of use, or territories. 4. Research Collaboration Collateral License Agreement: This agreement enables Gentling, Inc. to collaborate with The University of North Texas Health Science Center on research projects using the intellectual property, with provisions for sharing and commercialization of the results. 5. Development and Commercialization Collateral License Agreement: This type of agreement focuses on allowing Gentling, Inc. to develop and commercialize products or services based on the licensed intellectual property, with provisions for revenue sharing and royalties between the parties. 6. Master Collateral License Agreement: This comprehensive agreement covers multiple intellectual properties or patents and provides a framework for collaboration, commercialization, and shared rights between Gentling, Inc. and The University of North Texas Health Science Center. The type of Collateral License Agreement entered into by Gentling, Inc. and The University of North Texas Health Science Center will depend on the specific objectives, needs, and nature of the intellectual property involved in the collaboration.

The Dallas Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal agreement outlining the terms and conditions regarding the use, ownership, and commercialization of intellectual property between the two entities. This agreement establishes a mutually beneficial partnership with a focus on promoting scientific research, technology transfer, and innovation. Keywords: Dallas Texas Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property, ownership, commercialization, partnership, scientific research, technology transfer, innovation. Types of Dallas Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center: 1. Exclusive Collateral License Agreement: This type of agreement grants Gentling, Inc. exclusive rights to use, develop, and commercialize the intellectual property exclusively within the designated field or market. 2. Non-exclusive Collateral License Agreement: This agreement allows Gentling, Inc. non-exclusive rights to utilize the intellectual property alongside other licenses granted to other parties by The University of North Texas Health Science Center. 3. Limited Collateral License Agreement: In this type of agreement, Gentling, Inc. is granted limited rights to use the intellectual property within specific parameters, usually with restrictions on duration, field of use, or territories. 4. Research Collaboration Collateral License Agreement: This agreement enables Gentling, Inc. to collaborate with The University of North Texas Health Science Center on research projects using the intellectual property, with provisions for sharing and commercialization of the results. 5. Development and Commercialization Collateral License Agreement: This type of agreement focuses on allowing Gentling, Inc. to develop and commercialize products or services based on the licensed intellectual property, with provisions for revenue sharing and royalties between the parties. 6. Master Collateral License Agreement: This comprehensive agreement covers multiple intellectual properties or patents and provides a framework for collaboration, commercialization, and shared rights between Gentling, Inc. and The University of North Texas Health Science Center. The type of Collateral License Agreement entered into by Gentling, Inc. and The University of North Texas Health Science Center will depend on the specific objectives, needs, and nature of the intellectual property involved in the collaboration.